SynCore Biotechnology Co.,Ltd (4192.TWO)
TWD 28.95
(-9.95%)
TWD 28.95
(-9.95%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -38.17 Million TWD | 79.77% |
| 2022 | -188.66 Million TWD | 58.86% |
| 2021 | -458.59 Million TWD | -14.96% |
| 2020 | -398.91 Million TWD | 2.38% |
| 2019 | -408.63 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -13.49 Million TWD | -0.91% |
| 2024 Q1 | -13.37 Million TWD | -132.13% |
| 2023 Q4 | 41.61 Million TWD | 241.23% |
| 2023 FY | -38.17 Million TWD | 79.77% |
| 2023 Q2 | -26.39 Million TWD | -10.31% |
| 2023 Q1 | -23.92 Million TWD | 70.73% |
| 2023 Q3 | -29.46 Million TWD | -11.64% |
| 2022 FY | -188.66 Million TWD | 58.86% |
| 2022 Q4 | -81.73 Million TWD | 0.0% |
| 2021 FY | -458.59 Million TWD | -14.96% |
| 2020 FY | -398.91 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | 26.283% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 115.207% |
| Level Biotechnology Inc. | 62.9 Million TWD | 160.682% |
| Sagittarius Life Science Corp | -55.03 Million TWD | 30.646% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | 40.951% |
| TaiMed Biologics Inc. | -194.81 Million TWD | 80.406% |
| GlycoNex Incorporation | -178.36 Million TWD | 78.599% |
| VBI | -6.6 Million TWD | -478.276% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | 77.042% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | -257.349% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 77.287% |
| Visgeneer Inc. | -19.58 Million TWD | -94.864% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 94.41% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 106.101% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 152.724% |
| Neith Corporation | -40.03 Million TWD | 4.649% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 96.709% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -531.255% |
| Enimmune corporation | -223.74 Million TWD | 82.939% |
| TaiRx, Inc. | -212.29 Million TWD | 82.019% |
| CHO Pharma, Inc. | -306.08 Million TWD | 87.529% |
| EirGenix Inc. | -915.2 Million TWD | 95.829% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 176.738% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | 39.716% |
| Lin BioScience, Inc. | -687.19 Million TWD | 94.445% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 75.582% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | 267.48% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | 47.913% |
| Lukas Biomedical Inc. | -47.35 Million TWD | 19.388% |
| RBC Bioscience Corporation | 6.43 Million TWD | 693.655% |
| BiOptic Inc. | 37.74 Million TWD | 201.126% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 94.452% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | -2.71% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 37.972% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 113.889% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 58.558% |
| NaviFUS Corp. | -65.72 Million TWD | 41.925% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 56.667% |
| Sinew Pharma Inc. | -170.92 Million TWD | 77.667% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 43.996% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 129.214% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 83.964% |
| AP Biosciences Inc | -339.29 Million TWD | 88.75% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 93.199% |
| 3D Global Biotech Inc. | -57.95 Million TWD | 34.131% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | 551.419% |
| Intech Biopharm Corporation | -337.98 Million TWD | 88.706% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 97.092% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | 26.042% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | 77.636% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 107.077% |
| TCI GENE Inc. | 11.67 Million TWD | 427.011% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 70.072% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | 87.117% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 82.451% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 477.194% |
| PharmaEngine, Inc. | 274.65 Million TWD | 113.898% |
| Savior Lifetec Corporation | 30.03 Million TWD | 227.113% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 127.918% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 96.352% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | 69.547% |
| Acepodia, Inc. | -817.31 Million TWD | 95.33% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 92.185% |